Literature DB >> 28164107

Vascular changes and perifascicular muscle fiber damage in dermatomyositis: another question of the chicken or the egg that is on our mind.

Boel De Paepe1.   

Abstract

Entities:  

Year:  2017        PMID： 28164107      PMCID： PMC5253287          DOI： 10.21037/atm.2016.12.68

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  15 in total

Review 1.  Function of RIG-I-like receptors in antiviral innate immunity.

Authors:  Mitsutoshi Yoneyama; Takashi Fujita
Journal:  J Biol Chem       Date:  2007-03-29       Impact factor: 5.157

2.  Microvascular changes in early and advanced dermatomyositis: a quantitative study.

Authors:  A M Emslie-Smith; A G Engel
Journal:  Ann Neurol       Date:  1990-04       Impact factor: 10.422

3.  Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.

Authors:  Xavier Suárez-Calvet; Eduard Gallardo; Gisela Nogales-Gadea; Luis Querol; Miquel Navas; Jordi Díaz-Manera; Ricard Rojas-Garcia; Isabel Illa
Journal:  J Pathol       Date:  2014-04-29       Impact factor: 7.996

4.  The nonnecrotic invaded muscle fibers of polymyositis and sporadic inclusion body myositis: on the interplay of chemokines and stress proteins.

Authors:  Boel De Paepe; Jan L De Bleecker
Journal:  Neurosci Lett       Date:  2013-01-04       Impact factor: 3.046

5.  Heat shock protein families 70 and 90 in Duchenne muscular dystrophy and inflammatory myopathy: balancing muscle protection and destruction.

Authors:  Boel De Paepe; Kim K Creus; Joachim Weis; Jan L De Bleecker
Journal:  Neuromuscul Disord       Date:  2011-08-19       Impact factor: 4.296

Review 6.  Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.

Authors:  Syed A Haq; Anne Tournadre
Journal:  Int J Rheum Dis       Date:  2015-09-19       Impact factor: 2.454

7.  The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody.

Authors:  Ran Nakashima; Yoshitaka Imura; Shio Kobayashi; Naoichiro Yukawa; Hajime Yoshifuji; Takaki Nojima; Daisuke Kawabata; Koichiro Ohmura; Takashi Usui; Takao Fujii; Katsuya Okawa; Tsuneyo Mimori
Journal:  Rheumatology (Oxford)       Date:  2009-12-16       Impact factor: 7.580

8.  Microvascular alterations and the role of complement in dermatomyositis.

Authors:  Rajat Lahoria; Duygu Selcen; Andrew G Engel
Journal:  Brain       Date:  2016-05-16       Impact factor: 13.501

9.  Microvascular deposition of complement membrane attack complex in dermatomyositis.

Authors:  J T Kissel; J R Mendell; K W Rammohan
Journal:  N Engl J Med       Date:  1986-02-06       Impact factor: 91.245

Review 10.  Role of cytokines and chemokines in idiopathic inflammatory myopathies.

Authors:  Boel De Paepe; Kim K Creus; Jan L De Bleecker
Journal:  Curr Opin Rheumatol       Date:  2009-11       Impact factor: 5.006
View more
  4 in total

Review 1.  Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review.

Authors:  Renske G Kamperman; Anneke J van der Kooi; Marianne de Visser; Eleonora Aronica; Joost Raaphorst
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

2.  Co-expression network analysis reveals the pivotal role of mitochondrial dysfunction and interferon signature in juvenile dermatomyositis.

Authors:  Danli Zhong; Chanyuan Wu; Jingjing Bai; Dong Xu; Xiaofeng Zeng; Qian Wang
Journal:  PeerJ       Date:  2020-02-18       Impact factor: 2.984

3.  Polymyositis/dermatomyositis is a potential risk factor for acute respiratory failure: a pulmonary heart disease.

Authors:  Shih-Huei Syue; Yi-Hua Chang; Pei-Ju Shih; Cheng-Li Lin; Jun-Jun Yeh; Chia-Hung Kao
Journal:  Ann Transl Med       Date:  2020-03

Review 4.  Role of Immunoglobulins in Muscular Dystrophies and Inflammatory Myopathies.

Authors:  Andrea Farini; Chiara Villa; Luana Tripodi; Mariella Legato; Yvan Torrente
Journal:  Front Immunol       Date:  2021-07-14       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.